Humoral response to influenza vaccination in relation to pre-vaccination antibody titres, vaccination history, cytomegalovirus serostatus and CD4/CD8 ratio

References

• Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine. 2006;24:1159–169.
   PubMed Web of Science ®Google Scholar
• Goronzy JJ, Fulbright JW, Crowson CS, et al. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol. 2001;75:12182–12187.
   PubMed Web of Science ®Google Scholar
• Mahnke YD, Saqr A, Hazenfeld S, et al. Age-related changes in durability and function of vaccine-elicited influenza-specific CD4(+) T-cell responses. Vaccine. 2011;29:8606–8614.
   PubMed Web of Science ®Google Scholar
• Gross PA, Hermogenes AW, Sacks HS, et al. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med. 1995;123:518–527.
   PubMed Web of Science ®Google Scholar
• Saurwein-Teissl M, Lung TL, Marx F, et al. Lack of antibody production following immunization in old age: association with CD8(+)CD28(−) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol. 2002;168:5893–5899.
   PubMed Web of Science ®Google Scholar
• Xie D, McElhaney JE. Lower GrB + CD62Lhigh CD8 TCM effector lymphocyte response to influenza virus in older adults is associated with increased CD28null CD8 T lymphocytes. Mech Ageing Dev. 2007;128:392–400.
   PubMed Web of Science ®Google Scholar
• Grubeck-Loebenstein B, Della Bella S, Iorio AM, et al. Immunosenescence and vaccine failure in the elderly. Aging Clin Exp Res. 2009;21:201–209.
   PubMed Web of Science ®Google Scholar
• Koch S, Larbi A, Ozcelik D, et al. Cytomegalovirus infection: a driving force in human T cell immunosenescence. Ann N Y Acad Sci. 2007;1114:23–35.
   PubMed Web of Science ®Google Scholar
• Olsson J, Wikby A, Johansson B, et al. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev. 2000;121:187–201.
   PubMed Web of Science ®Google Scholar
• Pawelec G, Derhovanessian E, Larbi A, et al. Cytomegalovirus and human immunosenescence. Rev Med Virol. 2009;19:47–56.
   PubMed Web of Science ®Google Scholar
• Wikby A, Johansson B, Olsson J, et al. Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp Gerontol. 2002;37:445–453.
   PubMed Web of Science ®Google Scholar
• Pawelec G. Immunosenenescence: role of cytomegalovirus. Exp Gerontol. 2014;54C:1–5.
   Web of Science ®Google Scholar
• Turner JE, Campbell JP, Edwards KM, et al. Rudimentary signs of immunosenescence in Cytomegalovirus-seropositive healthy young adults. Age (Dordr). 2014;36:287–297.
   PubMed Web of Science ®Google Scholar
• Wald A, Selke S, Magaret A, Boeckh M. Impact of human cytomegalovirus (CMV) infection on immune response to pandemic 2009 H1N1 influenza vaccine in healthy adults. J Med Virol. 2013;85:1557–1560.
   PubMed Web of Science ®Google Scholar
• Derhovanessian E, Theeten H, Hahnel K, et al. Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral response to influenza vaccination. Vaccine. 2013;31:685–690.
   PubMed Web of Science ®Google Scholar
• Trzonkowski P, Mysliwska J, Szmit E, et al. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination–an impact of immunosenescence. Vaccine. 2003;21:3826–3836.
   PubMed Web of Science ®Google Scholar
• den Elzen WP, Vossen AC, Cools HJ, et al. Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities. Vaccine. 2011;29:4869–4874.
   PubMed Web of Science ®Google Scholar
• Furman D, Jojic V, Sharma S, et al. Cytomegalovirus infection enhances the immune response to influenza. Sci Trans Med. 2015;7:281ra43.
   PubMed Web of Science ®Google Scholar
• Derhovanessian E, Maier AB, Hahnel K, et al. Latent infection with cytomegalovirus is associated with poor memory CD4 responses to influenza A core proteins in the elderly. J Immunol. 2014;193:3624–3631.
   PubMed Web of Science ®Google Scholar
• Gaglani M, Spencer S, Ball S, et al. Antibody response to influenza A(H1N1)pdm09 among healthcare personnel receiving trivalent inactivated vaccine: effect of prior monovalent inactivated vaccine. J Infect Dis. 2014;209:1705–1714.
   PubMed Web of Science ®Google Scholar
• Kunzel W, Glathe H, Engelmann H, Van Hoecke C. Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time. Vaccine. 1996;14:1108–1110.
   PubMed Web of Science ®Google Scholar
• Beyer WE, de Bruijn IA, Palache AM, et al. Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies. Arch Intern Med. 1999;159:182–188.
   PubMedGoogle Scholar
• de Bruijn IA, Remarque EJ, Beyer WE, et al. Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly. Vaccine. 1997;15:1323–1329.
   PubMed Web of Science ®Google Scholar
• Hoskins TW, Davies JR, Smith AJ, et al. Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ’s Hospital. Lancet. 1979;1:33–35.
   PubMed Web of Science ®Google Scholar
• Ohmit SE, Thompson MG, Petrie JG, et al. Influenza vaccine effectiveness in the 2011–2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis. 2014;58:319–327.
   PubMed Web of Science ®Google Scholar
• Ahmed AE, Nicholson KG, Nguyen-Van-Tam JS. Reduction in mortality associated with influenza vaccine during 1989–90 epidemic. Lancet. 1995;346:591–595.
   PubMed Web of Science ®Google Scholar
• Keitel WA, Cate TR, Couch RB, et al. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine. 1997;15:1114–1122.
   PubMed Web of Science ®Google Scholar
• Voordouw AC, Sturkenboom MC, Dieleman JP, et al. Annual revaccination against influenza and mortality risk in community-dwelling elderly persons. JAMA. 2004;292:2089–2095.
   PubMed Web of Science ®Google Scholar
• Wikby A, Maxson P, Olsson J, et al. Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study. Mech Ageing Dev. 1998;102:187–198.
   PubMed Web of Science ®Google Scholar
• Ferguson FG, Wikby A, Maxson P, et al. Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J Gerontol A Biol Sci Med Sci. 1995;50:B378–B382.
   PubMed Web of Science ®Google Scholar
• Potter CW, Oxford JS. Determinants of immunity to influenza infection in man. Br Med Bull. 1979;35:69–75.
   PubMed Web of Science ®Google Scholar
• Couch RB, Kasel JA. Immunity to influenza in man. Ann Rev Microbiol. 1983;37:529–549.
   PubMed Web of Science ®Google Scholar
• Strindhall J, Skog M, Ernerudh J, et al. The inverted CD4/CD8 ratio and associated parameters in 66-year-old individuals: the Swedish HEXA immune study. Age (Dordr). 2013;35:985–991.
   PubMed Web of Science ®Google Scholar
• Waalen K, Kilander A, Dudman SG, et al. High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009. Euro Surveill. 2010;15.
   PubMedGoogle Scholar
• Davenport FM, Hennessy AV, Francis T Jr. Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus. J Exp Med. 1953;98:641–656.
   PubMed Web of Science ®Google Scholar
• Kim JH, Skountzou I, Compans R, Jacob J. Original antigenic sin responses to influenza viruses. J Immunol. 2009;183:3294–3301.
   PubMed Web of Science ®Google Scholar
• Sun J, Braciale TJ. Role of T cell immunity in recovery from influenza virus infection. Curr Opin Virol. 2013;3:425–429.
   PubMed Web of Science ®Google Scholar
• Govaert TM, Sprenger MJ, Dinant GJ, et al. Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial. Vaccine. 1994;12:1185–1189.
   PubMed Web of Science ®Google Scholar
• Muszkat M, Friedman G, Dannenberg HD, et al. Response to influenza vaccination in community and in nursing home residing elderly: relation to clinical factors. Exp Gerontol. 2003;38:1199–1203.
   PubMed Web of Science ®Google Scholar
• Sasaki S, He XS, Holmes TH, et al. Influence of prior influenza vaccination on antibody and B-cell responses. PLoS One. 2008;3:e2975.
   PubMed Web of Science ®Google Scholar
• Iorio AM, Camilloni B, Basileo M, et al. Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers. Gerontology. 2007;53:411–418.
   PubMed Web of Science ®Google Scholar
• Burns VE, Gallagher S. Antibody response to vaccination as a marker of in vivo immune function in psychophysiological research. Neurosci Biobehav Rev. 2010;35:122–126.
   PubMed Web of Science ®Google Scholar
• Edwards KM, Campbell JP, Ring C, et al. Exercise intensity does not influence the efficacy of eccentric exercise as a behavioural adjuvant to vaccination. Brain Behav Immun. 2010;24:623–630.
   PubMed Web of Science ®Google Scholar
• Smith DJ, Forrest S, Ackley DH, Perelson AS. Variable efficacy of repeated annual influenza vaccination. Proc Natl Acad Sci U S A. 1999;96:14001–14006.
   PubMed Web of Science ®Google Scholar
• Beyer WE, Palache AM, Sprenger MJ, et al. Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults. Vaccine. 1996;14:1331–1339.
   PubMed Web of Science ®Google Scholar
• Nabeshima S, Kashiwagi K, Murata M, et al. Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years. J Med Virol. 2007;79:320–325.
   PubMed Web of Science ®Google Scholar
• Wagar LE, Gentleman B, Pircher H, et al. Influenza-specific T cells from older people are enriched in the late effector subset and their presence inversely correlates with vaccine response. PLoS One. 2011;6:e23698.
   PubMed Web of Science ®Google Scholar